Minnesota will no longer allow hotel rooms to be used for crisis respite, a Medicaid-funded program that provides care and supervision to people experiencing mental health crises, MPR News reported Sept. 14. The state stopped allowing new hotel placements in…
The Latest
In high-cost markets, hospital staff increasingly earn too much to qualify for housing aid yet too little to afford a home near work. The strain lands on operations: longer commutes, harder recruiting, higher turnover and rising labor costs. The scale…
Presented by:
Benzodiazepine use among Americans over 75 increased from 12% in 2020 to about 13% in 2024, even as concerns persist about the drugs’ risks for older adults, The New York Times reported Sept. 5. A recent study published in Annals…
Life expectancy among Medicaid beneficiaries with autism spectrum disorder was 13.8 years shorter than among the U.S. general population, according to a study published Sept. 10 in JAMA Network Open. Researchers from New York City-based Columbia University and University of…
Molecular residual disease (MRD) testing is moving into the next phase of precision oncology, extending molecular insight past diagnosis and treatment selection into post-treatment monitoring, surveillance and survivorship. For health systems, the question is not whether to add another test.…
Presented by:
- Rick Baehner, MD, Chief Medical Officer, Precision Oncology Abbott Cancer Diagnostics, Clinical Professor of Pathology,, University of California, San Francisco
Many healthcare organizations are exploring AI, but moving from experimentation to meaningful operational impact remains a challenge. Join Omkar Kulkarni, Vice President and Chief Innovation & Transformation Officer, and Amani Zaki, Manager of Language and Cultural Services at Children’s Hospital…
Presented by:
- Omkar Kulkarni, Chief Innovation Officer, CHLA
- Amani Zaki, Language and Cultural Services Manager, CHLA
- Julie Wilner, Vice President of AI Solutions Operations, AMN Healthcare Language Services
- Joe Corkery, MD, Vice President of AI Solutions Strategy,, AMN Healthcare Language Services
Eligibility churn and redetermination pressure remain significant for revenue cycle teams, but they’re no longer the whole story. Heading into 2027, new Medicaid community engagement and six-month renewal requirements will add eligibility complexity for affected populations, while Medicare payment updates…
Presented by:
- Sarah Brainard, Vice President of Enterprise Solutions, Office Ally
- Marji Karlin, MBA, Chief Revenue Officer, NYC Health + Hospitals
- Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, FAHIMA, Assistant Vice President Revenue Integrity, Revenue Cycle, Montefiore Medical Center
Rural and underserved hospitals nationwide face a growing challenge: widening gaps in specialty care. A Becker’s Healthcare survey of 100 hospital and health system leaders across roughly 30 states suggests the primary issue isn’t technology — it’s a shortage of…
Presented by:
- Penni Kyte, Vice President of Digital Strategy, Ballad Health
- Dr. Raj Narula, CEO, Sevaro Health
- Dr. Chethan Sathya, Co-Chair, National Specialty Care Access Coalition
- Sai Yendamuri, MD, MBA, FACS, Chief Strategy Officer; Professor and Chair of Thoracic Surgery, Roswell Park Comprehensive Cancer Center
- Jeremy Cauwels, MD, FACP, FHM, Chief Medical Officer, Sanford Health
- Tori Ames, Senior Director, Telehealth, Cincinnati Children's
Kenvue and several major pharmacy and retail chains have asked the 2nd Circuit U.S. Court of Appeals to reconsider its July ruling that reinstated roughly 550 lawsuits alleging prenatal acetaminophen use contributed to autism spectrum disorder or ADHD in children,…
A potent new synthetic opioid is spreading through the illicit drug supply, and federal officials are warning it’s harder to detect and harder to reverse than fentanyl alone. Cychlorphine has been linked to dozens of deaths since 2025, and it…
